The Clorox Company $CLX Shares Sold by Tredje AP fonden

Tredje AP fonden decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 32.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,107 shares of the company’s stock after selling 5,389 shares during the quarter. Tredje AP fonden’s holdings in Clorox were worth $1,369,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of CLX. Center for Financial Planning Inc. purchased a new position in shares of Clorox during the 3rd quarter worth $25,000. Total Investment Management Inc. purchased a new position in Clorox during the second quarter worth about $25,000. True Wealth Design LLC increased its position in shares of Clorox by 1,020.0% during the third quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after acquiring an additional 204 shares during the last quarter. NewSquare Capital LLC increased its position in shares of Clorox by 567.6% during the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after acquiring an additional 193 shares during the last quarter. Finally, Root Financial Partners LLC purchased a new stake in shares of Clorox in the 3rd quarter valued at approximately $29,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Zacks raised its FY2028 EPS view to $7.23 and upgraded select quarterly/annual estimates (including Q1 2028 to $1.37 and Q4 2026/2027 increases), signaling modestly better forward earnings visibility that can support the stock.
• Positive Sentiment: Clorox published a consumer research report “Home Care Redefined” that underscores evolving demand for wellness- and convenience-oriented home-care products — a strategic tailwind for branded consumer staples. Home Care Redefined
• Neutral Sentiment: Management presented at the Consumer Analyst Group of New York (CAGNY) conference; slides and prepared remarks provide more detail on strategy, cost actions and growth initiatives — useful for longer-term positioning but not an immediate earnings surprise. CAGNY Slides Transcript
• Negative Sentiment: Zacks trimmed multiple near-term quarterly EPS forecasts (several Q2–Q3 2026/2027 cuts and FY2027 lowered to $6.74), reflecting caution about near-term volume/mix or cost pressure — a potential headwind for sentiment and short-term guidance expectations.
• Negative Sentiment: Wells Fargo issued a “Hold” on CLX (reported as “receives a Hold”), which keeps sell-side sentiment neutral-to-cautious and may limit near-term upside from upgrades. Wells Fargo Hold

Clorox Stock Performance

NYSE:CLX opened at $123.51 on Monday. The Clorox Company has a 52 week low of $96.66 and a 52 week high of $159.04. The company has a fifty day simple moving average of $109.75 and a two-hundred day simple moving average of $113.51. The company has a quick ratio of 0.48, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The company has a market cap of $14.93 billion, a price-to-earnings ratio of 20.18, a price-to-earnings-growth ratio of 0.61 and a beta of 0.59.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the business posted $1.55 earnings per share. The firm’s revenue was down .8% on a year-over-year basis. As a group, equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Evercore decreased their price target on Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a research note on Wednesday, February 4th. UBS Group raised their price target on Clorox from $115.00 to $121.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 4th. Rothschild & Co Redburn set a $117.00 price objective on Clorox in a research note on Friday, February 13th. Finally, JPMorgan Chase & Co. boosted their price objective on Clorox from $114.00 to $117.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $118.73.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.